Automated insulin delivery and lower burden of hypoglycemia in type 1 diabetes: a prospective analysis of the BETTER registry - 16/11/26

Highlights |
• | Automated insulin delivery reduced fear of hypoglycemia and related behaviors. |
• | Fear of hypoglycemia improved more than in people continuing daily injections. |
• | Automated insulin delivery eased worries about safety, cognition and social judgment. |
• | Lower hypoglycemia alone may not resolve fear; assess specific worries and behaviors. |
Abstract |
Background |
Automated insulin delivery (AID) systems are expected to reduce the burden of hypoglycemia, including fear of hypoglycemia (FOH), but evidence on how they might shape management behaviors in type 1 diabetes (T1D) is not well defined. This study evaluates changes in Hypoglycemia Fear Survey-II (HFS-II) scores and FOH related worries and behaviors after AID initiation compared with non-AID use.
Methods |
In this prospective analysis, participants from the BETTER registry were categorized into three groups: multiple daily injections (MDI) users at baseline and follow-up, continuous subcutaneous insulin infusion (CSII) users at baseline and follow-up, and AID group (MDI or CSII at baseline, started AID during follow-up). Pairwise comparisons were conducted using propensity score–weighted generalized linear regression models.
Results |
Among 466 participants, 66% were women, mean age and diabetes duration were 46.6 ± 14.8 and 26.0 ± 15.8 years, respectively. HFS-II total and subscale scores were not statistically different at baseline between the three groups (all P> 0.05). At follow-up, AID initiation was associated with lower HFS-II total (-4.05 [-7.04, -1.06], worry (-2.27 [-4.34, -0.20]), and behavior scores (-1.78 [-3.22, -0.33]) compared to baseline. In contrast, MDI users reported less favorable changes in HFS-II total (3.86 [0.21, 7.52]) and behavior scores (2.06 [0.33, 3.80]) compared to AID. Overall, the results remained consistent after adjustment for baseline HFS-II score and change in hypoglycemia frequency. AID users were more likely to meet target hemoglobin A1c ≤7% at follow-up.
Conclusion |
Findings suggest AID use may influence FOH-related behaviors without compromising overall glycemic outcomes.
Le texte complet de cet article est disponible en PDF.Keywords : Automated insulin delivery, Fear of hypoglycemia, Hypoglycemia avoidance, Type 1 diabetes
Plan
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
